Abstract
Current therapy of acromegaly is unsatisfactory, and in a significant proportion of acromegalic patients the disease remains clinically active after all approved therapeutic modalities (surgery, irradiation and bromocriptine) have been exhausted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barkan AL, Kelch RP, Hopwood NJ, Beitins IZ (1988) Treatment of acromegaly with the long-acting somatostatin analogue SMS 201-995. J Clin Endocrinol Metab 66: 16
Barkan AL, Shenker Y, Grekin RJ, Vale WW (1988) Acromegaly due to ectopic GHRH secretion by malignant carcinoid tumor: successful treatment with long-acting somatostatin analogue SMS 201-995. Cancer 61: 221
Billestrup N, Swanson LW, Vale WW (1986) Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA 83: 6854
Chiodini PG, Cozzi R, Dallabonzana D, Opizzi G, Verde G, Petroncini M, Liuzzi A, Del Pozo E (1987) Medical treatment of acromegaly with SMS 201-995, a somatostatin analogue: a comparison with bromocriptine. J Clin Endocrinol Metab 64: 447
Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD (1985) Bombesin-line peptides can function as auto-crine growth factors in human small-cell lung cancer. Nature 316: 823
Landolt AM, Keller PJ, Froesch ER, Mueller J (1982) Bromocriptine: does it jeopardize the result of later surgery for prolactinomas? Lancet II: 657
Reubi JC, Heitz PU, Landolt AM (1987) Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses. J Clin Endocrinol Metab 65: 65
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
Barkan, A.L. et al. (1988). Treatment of Acromegaly with SMS 201–995 (Sandostatin®): Clinical, Biochemical and Morphologic Study. In: Lamberts, S.W.J. (eds) Sandostatin® in the Treatment of Acromegaly. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73694-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-73694-0_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73696-4
Online ISBN: 978-3-642-73694-0
eBook Packages: Springer Book Archive